April 2nd, 2020
Nanoneedle technology licensed for early disease detection, biomarker discovery, and more
Startup NanoMosaic to commercialize high-sensitivity tool for protein detection and quantification
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Diagnostics
April 1st, 2020
From the lab to COVID front lines
Technology developed at Harvard provides early boost to Mass. COVID testing
March 21st, 2019
Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics
Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings
May 18th, 2016
Harvard licenses genotyping platform to startup Aldatu Biosciences
Novel qPCR platform enables development of drug resistance testing products for HIV
